3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Colorectal Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Thyroid Cancer, Papillary
1
Thymoma
1
Surgery
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Neoadjuvant Chemoimmunotherapy
1
Myasthenia Gravis
1
Menstruation Disturbances
1
Lymphatic Metastasis
1
Leiomyoma
1
Invasive Breast Carcinoma
1
Gastrointenstinal Stromal Tumor (GIST)
1
Esophageal Neoplasms
1
Endometriosis
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Adenomyosis
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
Biopsy
3
fludarabine
2
Patient Reported Outcome Measures
2
Mesna
2
Colposcopy
2
Aminolevulinic Acid
2
tirbanibulin
1
ruxolitinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Thalidomide
1
Tamoxifen
1
Sirolimus
1
Robotic Surgical Procedures
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Nivolumab
1
Methotrexate
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
Robotic Surgical Procedures
×
1 year
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled